Triamcinolone acetonide and botulinum toxin A for upper eyelid retraction in thyroid-associated ophthalmopathy. [PDF]
Huang Z, Xu M, Zhang W, Song X.
europepmc +1 more source
Can chimeric antigen receptors - based therapy bring a gleam of hope for thyroid-associated ophthalmopathy and other autoimmune diseases? [PDF]
Zhou W, Zhu X, Shi Y.
europepmc +1 more source
Thyroid-associated ophthalmopathy and ferroptosis: a review of pathological mechanisms and therapeutic strategies. [PDF]
Ma C, Li H, Lu S, Li X.
europepmc +1 more source
Correlation between orbital imaging features of thyroid-associated ophthalmopathy and pupillary light reflex measurement. [PDF]
Li Y, Zhu Z, Lu Y, Lin Q, Liu M, Li Z.
europepmc +1 more source
Monocyte to high-density lipoprotein cholesterol ratio as a predictor of the activity of thyroid-associated ophthalmopathy. [PDF]
Sun XH +7 more
europepmc +1 more source
In Vitro Investigation of HIF-1α as a Therapeutic Target for Thyroid-Associated Ophthalmopathy. [PDF]
Lee J +9 more
europepmc +1 more source
Negative association between serum calcium and glucocorticoid-induced hypertension in thyroid-associated ophthalmopathy patients treated with methylprednisolone. [PDF]
Wang L +12 more
europepmc +1 more source
White matter structural changes in the visual pathway of thyroid-associated ophthalmopathy patients: a free water and multi-shell diffusion imaging study. [PDF]
Yao J +7 more
europepmc +1 more source
Signatures of Six Autophagy-Related Genes as Diagnostic Markers of Thyroid-Associated Ophthalmopathy and Their Correlation With Immune Infiltration. [PDF]
Ma Q, Hai Y, Shen J.
europepmc +1 more source
Kontroversen in der Behandlung benigner Schilddrüsenerkrankungen [PDF]
Gärtner, Roland +2 more
core

